The risk for COVID-19-related hospitalization was not significantly different between vaccinated older adults with vs without age-restrictive access to nirmatrelvir-ritonavir.

Among the 43 evaluable patients treated with sevabertinib, the confirmed objective response rate was 72.1%.

Certain air pollutants were associated with changes in metabolites among postmenopausal women in the US, potentially impacting bone health.

Colorado has reported 11 cases, including one 3-case outbreak, in relation to the 1088-case nationwide spread of measles in 2025.

Vaping persistence rates were lower in adolescents who used oral nicotine products including nicotine pouches.

Pediatric community-acquired pneumonia severity can be predicted accurately with 7 factors based on a new model.

RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.

The FDA has approved Nucala (mepolizumab) for the add-on maintenance treatment of patients with inadequately controlled eosinophilic COPD.

Pediatric patients exhibited high risk for severe avian influenza A/H5N1, suggesting clinical therapeutic and vaccine trials should be prioritized in this population.

The HHS terminated funding for for Moderna's avian influenza vaccine due to safety concerns with mRNA vaccines.

In PAH, 5-year mortality is similar with and without obesity, even though patients with obesity have more comorbidities and worse functional capacity.

Maternal vaccination and, to a lesser extent, nirsevimab appear to significantly reduce RSV-related hospitalizations in infants.